Total Synthesis of Marine-Derived Alkaloids of the Nagelamide Family
Nagelamide 家族海洋生物碱的全合成
基本信息
- 批准号:8101666
- 负责人:
- 金额:$ 24.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-13 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:AgelasAlkaloidsAnti-Bacterial AgentsAzidesBiologicalBiological FactorsBiological TestingChemistryCollaborationsComplexCoupledCouplingDevelopmentExhibitsFamilyFamily memberGenerationsHydantoinsImidazoleInvestigationLiteratureMarinesMethodsPalau&aposaminePalladiumParentsPatternPoriferaPositioning AttributePreparationProcessProtocols documentationPyrrolesReactionReagentReportingRunningSamplingSideSkeletonStagingSynthesis ChemistrySystemTherapeutic AgentsUnited States National Institutes of HealthWorkadductanalogdimerinterestmembernovelnovel therapeuticsoperationoroidinoxidationprograms
项目摘要
DESCRIPTION (provided by applicant): Marine alkaloids containing 2-aminoamidazoles provide targets of opportunity for not only the development of novel synthetic chemistry, but also for the generation of novel therapeutic agents or biological probes. In this effort, we have chosen to focus on several related natural products from the oroidin family of sponge metabolites that range in complexity and provide a forum to develop new synthetic methods and strategies. Specifically, we propose to develop synthetic approaches to several of anti-bacterial alkaloids known as the nagelamides. Our strategy is centered on the elaboration of simple imidazoles, specifically the functionalization of 4,5-diiodoimidazole derivatives, which provides a straightforward approach for the construction of useful imidazole-containing building blocks. In the first Specific Aim we propose to develop total syntheses of two closely related oroidin dimers, nagelamide B, and C through a fragment coupling strategy. Specifically, we will employ the sequential and position selective elaboration of 4,5-diiodoimidazoles with Grignard reagents to prepare two functionalized vinylimidazoles, which will be coupled to provide the basic frameworks of the target nagelamides. Preliminary studies from our lab have demonstrated the general feasibility of the approach. In the second Specific Aim we propose to complete the total syntheses of nagelamide R and T. These oroidin dimers are unique within the pyrrole-imidazole family as they are the only reported examples to contain an oxazoline moiety. To approach these molecules, we plan on investigating a tandem palladium-catalyzed oxy-arylation reaction to construct the oxazoline
heterocycle and incorporate the second imidazole moiety. In the third Specific Aim we propose to examine a 6?-electrocyclization reaction of 4,5-divinylimidazoles to construct the tetrahydrobenzimidazole skeleton found in several oroidin-derived natural products. We plan on utilizing this chemistry to perform total syntheses of ageliferin and nagelamide E using nagelamide C as a precursor. Samples prepared in the course of this investigation will be offered to programs run by the NIH (NCI-DTP and MLSCN) to determine the bioactivities of synthetic natural products and advanced synthetic intermediates.
PUBLIC HEALTH RELEVANCE: Compounds derived from marine sponges typically possess a broad range of biological activities, in the present cases the compounds of interest exhibit anti-bacterial activity. In addition, they frequently demand the development of new synthetic methods and strategies for their assembly. The work described in this proposal aims to define and develop methods to provide synthetic access to reasonable quantities of several of these naturally occurring materials originally found in Agelas sp. marine sponges. Once obtained, the biological activity of these materials will be evaluated through NIH-sponsored programs.
描述(由申请人提供):含有2-氨基咪唑的海洋生物碱不仅为新型合成化学的发展提供了机会,而且为新型治疗剂或生物探针的产生提供了机会。在这项工作中,我们选择专注于海绵代谢物中oroidin家族的几个相关天然产物,这些产物的复杂性范围广泛,并为开发新的合成方法和策略提供了一个论坛。具体地说,我们建议开发几种抗菌生物碱的合成方法,这些生物碱被称为nagelamide。我们的策略集中于简单咪唑的细化,特别是4,5-二碘咪唑衍生物的功能化,这为构建有用的含咪唑构建块提供了一种直接的方法。在第一个特定目标中,我们建议通过片段偶联策略开发两种密切相关的oroidin二聚体nagelamide B和C的全合成。具体来说,我们将使用格氏试剂对4,5-二碘咪唑进行顺序和位置选择性精化,以制备两种功能化的乙烯基咪唑,它们将偶联以提供目标纳基酰胺的基本框架。我们实验室的初步研究已经证明了这种方法的总体可行性。在第二个特定目标中,我们建议完成nagelamide R和t的全合成。这些邻避蛋白二聚体在吡咯-咪唑家族中是独特的,因为它们是唯一报道的含有恶唑啉部分的例子。为了接近这些分子,我们计划研究钯催化的串联氧芳基化反应来构建恶唑啉
项目成果
期刊论文数量(1)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Thio acid-mediated conversion of azides to amides - exploratory studies en route to oroidin alkaloids.
硫代酸介导的叠氮化物向酰胺的转化——在制备蝴蝶苷生物碱的过程中的探索性研究。
- DOI:10.1016/j.tetlet.2017.08.050
- 发表时间:2017
- 期刊:
- 影响因子:1.8
- 作者:Herath,ApsaraK;Bhandari,ManojR;Gout,Delphine;Yousufuddin,Muhammed;Lovely,CarlJ
- 通讯作者:Lovely,CarlJ
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Carl Lovely其他文献
Carl Lovely的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Carl Lovely', 18)}}的其他基金
Approaches to Bioactive Aminoimidazole Natural Products
生物活性氨基咪唑天然产物的研究方法
- 批准号:
7173416 - 财政年份:2004
- 资助金额:
$ 24.22万 - 项目类别:
Approaches to Bioactive Aminoimidazole Natural Products
生物活性氨基咪唑天然产物的研究方法
- 批准号:
6837732 - 财政年份:2004
- 资助金额:
$ 24.22万 - 项目类别:
Approaches to Bioactive Aminoimidazole Natural Products
生物活性氨基咪唑天然产物的研究方法
- 批准号:
7338677 - 财政年份:2004
- 资助金额:
$ 24.22万 - 项目类别:
Approaches to Bioactive Aminoimidazole Natural Products
生物活性氨基咪唑天然产物的研究方法
- 批准号:
6731873 - 财政年份:2004
- 资助金额:
$ 24.22万 - 项目类别:
Approaches to Bioactive Aminoimidazole Natural Products
生物活性氨基咪唑天然产物的研究方法
- 批准号:
7175219 - 财政年份:2004
- 资助金额:
$ 24.22万 - 项目类别:
Approaches to Bioactive Aminoimidazole Natural Products
生物活性氨基咪唑天然产物的研究方法
- 批准号:
7005399 - 财政年份:2004
- 资助金额:
$ 24.22万 - 项目类别:
相似国自然基金
Iboga alkaloids骨架导向的不对称串联反应构建吖庚环并[4,5-b]吲哚及其在全合成中的应用
- 批准号:21801032
- 批准年份:2018
- 资助金额:26.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Investigation on naphthylisoquinoline alkaloids as potential antiausterity chemotherapy for pancreatic cancer
萘基异喹啉生物碱作为胰腺癌潜在抗紧缩化疗的研究
- 批准号:
23K26797 - 财政年份:2024
- 资助金额:
$ 24.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
CAREER: Chemoenzymatic Synthesis of Complex Polycyclic Alkaloids Enabled by A-Ketoglutarate Dependent Iron Enzymes
职业:通过 A-酮戊二酸依赖性铁酶实现复杂多环生物碱的化学酶法合成
- 批准号:
2338495 - 财政年份:2024
- 资助金额:
$ 24.22万 - 项目类别:
Continuing Grant
Strategy Driven Synthesis of Complex Alkaloids
复杂生物碱的策略驱动合成
- 批准号:
2400232 - 财政年份:2024
- 资助金额:
$ 24.22万 - 项目类别:
Standard Grant
Synthesis of guanidine alkaloids based on palladium catalyzed cyclization-carbonylation reactions.
基于钯催化环化-羰基化反应合成胍生物碱。
- 批准号:
23K06034 - 财政年份:2023
- 资助金额:
$ 24.22万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation on naphthylisoquinoline alkaloids as potential antiausterity chemotherapy for pancreatic cancer
萘基异喹啉生物碱作为胰腺癌潜在抗紧缩化疗的研究
- 批准号:
23H02104 - 财政年份:2023
- 资助金额:
$ 24.22万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Anthropogenic change and disease susceptibility in poison frogs: identifying links with diet, skin alkaloids, and the microbiome
毒蛙的人为变化和疾病易感性:确定与饮食、皮肤生物碱和微生物组的联系
- 批准号:
2882384 - 财政年份:2023
- 资助金额:
$ 24.22万 - 项目类别:
Studentship
Synthesis of Anticancer Alkaloids on Cancer Cells with Glycosylated Artificial Metalloenzymes
糖基化人工金属酶合成抗癌细胞生物碱
- 批准号:
22KJ1525 - 财政年份:2023
- 资助金额:
$ 24.22万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Discovery of analgesic diterpenoid alkaloids from medicinal Aconitum plants using a metabolomic approach
使用代谢组学方法从药用乌头植物中发现镇痛二萜生物碱
- 批准号:
10629875 - 财政年份:2023
- 资助金额:
$ 24.22万 - 项目类别:
Excellence in Research: Biosynthetic investigation of manzamine class alkaloids
卓越研究:曼扎明类生物碱的生物合成研究
- 批准号:
2302454 - 财政年份:2023
- 资助金额:
$ 24.22万 - 项目类别:
Standard Grant
Transition Metal-Catalyzed Reaction Development Toward the Synthesis of Alkaloids
过渡金属催化生物碱合成反应的进展
- 批准号:
2247315 - 财政年份:2023
- 资助金额:
$ 24.22万 - 项目类别:
Standard Grant














{{item.name}}会员




